Per Bayer’s communications, the contrast agent is manufactured at the same site in Berlin, Germany as the Ultravist that is intended for U.S. markets, but due to its intended distribution abroad it lacks current FDA-approved labeling. 

A retrospective analysis of cross-sectional venograms shows only 4.5% of a teaching hospital’s COVID-vaccinated patients had a clotting condition in early 2021. Meanwhile the rate for the unvaccinated was 10.1%.

Portable MRI maker Hyperfine is touting a new capability in its Swoop scanner that may appeal to pediatric neurologists and neurosurgeons as well as neuroradiologists.

The researchers are now working on developing a qMRI method that can be incorporated into clinical settings, with an anticipated timeline of three to five years. 

Image sharpness was further improved when sharper reconstruction kernels were used, despite having higher noise levels.

A machine learning system for planning spine surgery that also predicts post-op spinal alignment six months out has cleared the FDA’s 510(k) review process.

When counseling patients with architectural distortion on digital breast tomosynthesis (DBT) but no signs of malignancy on biopsy, mammographers should raise imaging alone as a sound option for surveillance.

The findings were discussed today at the annual meeting of the American Orthopaedic Society of Sports Medicine.